Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.220
+0.040 (3.39%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Milestone Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Milestone Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.33. The average 1-year stock price forecast is 418.85% higher than the current stock price, while the lowest is $2.00 (+63.93%) and the highest is $8.00 (+555.74%).
Price Target: $6.33 (+418.85%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Milestone Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $7 | Buy | Maintains | $7 | +473.77% | Jul 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $8 | Buy | Maintains | $8 | +555.74% | May 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $7 | Buy | Reiterates | $7 | +473.77% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $8 | Buy | Maintains | $8 | +555.74% | May 13, 2026 |
| Raymond James | Raymond James | Buy Initiates $6 | Buy | Initiates | $6 | +391.80% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
5.39M
from 1.55M
Increased by 248.89%
Revenue Next Year
25.14M
from 5.39M
Increased by 366.17%
EPS This Year
-0.83
from -0.75
EPS Next Year
-0.91
from -0.83
EPS and Forward PE are based on non-GAAP adjusted numbers.